220 related articles for article (PubMed ID: 19473103)
1. Histone acetyltransferase inhibitors and preclinical studies.
Manzo F; Tambaro FP; Mai A; Altucci L
Expert Opin Ther Pat; 2009 Jun; 19(6):761-74. PubMed ID: 19473103
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological testing of novel pyridoisothiazolones as histone acetyltransferase inhibitors.
Furdas SD; Shekfeh S; Bissinger EM; Wagner JM; Schlimme S; Valkov V; Hendzel M; Jung M; Sippl W
Bioorg Med Chem; 2011 Jun; 19(12):3678-89. PubMed ID: 21353783
[TBL] [Abstract][Full Text] [Related]
3. Assays for the identification and evaluation of histone acetyltransferase inhibitors.
Wynne Aherne G; Rowlands MG; Stimson L; Workman P
Methods; 2002 Mar; 26(3):245-53. PubMed ID: 12054880
[TBL] [Abstract][Full Text] [Related]
4. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
Mai A; Altucci L
Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibitors of histone acetyltransferase activity: identification and biological properties.
Mai A; Rotili D; Tarantino D; Ornaghi P; Tosi F; Vicidomini C; Sbardella G; Nebbioso A; Miceli M; Altucci L; Filetici P
J Med Chem; 2006 Nov; 49(23):6897-907. PubMed ID: 17154519
[TBL] [Abstract][Full Text] [Related]
6. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific histone deacetylase inhibitors: the next step?
Balasubramanian S; Verner E; Buggy JJ
Cancer Lett; 2009 Aug; 280(2):211-21. PubMed ID: 19289255
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the anti-cancer effects of histone deacetylase inhibitors.
Epping MT; Bernards R
Int J Biochem Cell Biol; 2009 Jan; 41(1):16-20. PubMed ID: 18765293
[TBL] [Abstract][Full Text] [Related]
9. Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors.
Prince HM; Bishton MJ; Johnstone RW
Future Oncol; 2009 Jun; 5(5):601-12. PubMed ID: 19519200
[TBL] [Abstract][Full Text] [Related]
10. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
11. Curcumin is an inhibitor of p300 histone acetylatransferase.
Marcu MG; Jung YJ; Lee S; Chung EJ; Lee MJ; Trepel J; Neckers L
Med Chem; 2006 Mar; 2(2):169-74. PubMed ID: 16787365
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
Gorsuch S; Bavetsias V; Rowlands MG; Aherne GW; Workman P; Jarman M; McDonald E
Bioorg Med Chem; 2009 Jan; 17(2):467-74. PubMed ID: 19101154
[TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors: a new perspective for the treatment of leukemia.
Abujamra AL; Dos Santos MP; Roesler R; Schwartsmann G; Brunetto AL
Leuk Res; 2010 Jun; 34(6):687-95. PubMed ID: 19762081
[TBL] [Abstract][Full Text] [Related]
15. Discovery and characterization of NK13650s, naturally occurring p300-selective histone acetyltransferase inhibitors.
Tohyama S; Tomura A; Ikeda N; Hatano M; Odanaka J; Kubota Y; Umekita M; Igarashi M; Sawa R; Morino T
J Org Chem; 2012 Oct; 77(20):9044-52. PubMed ID: 22984806
[TBL] [Abstract][Full Text] [Related]
16. CDK inhibitors in cancer therapy: what is next?
Malumbres M; Pevarello P; Barbacid M; Bischoff JR
Trends Pharmacol Sci; 2008 Jan; 29(1):16-21. PubMed ID: 18054800
[TBL] [Abstract][Full Text] [Related]
17. Rational combinations using HDAC inhibitors.
Bots M; Johnstone RW
Clin Cancer Res; 2009 Jun; 15(12):3970-7. PubMed ID: 19509171
[TBL] [Abstract][Full Text] [Related]
18. A dual-mode fluorescence strategy for screening HAT modulators.
Xie N; Elangwe EN; Asher S; Zheng YG
Bioconjug Chem; 2009 Feb; 20(2):360-6. PubMed ID: 19146394
[TBL] [Abstract][Full Text] [Related]
19. Histone acetyltransferases: challenges in targeting bi-substrate enzymes.
Wapenaar H; Dekker FJ
Clin Epigenetics; 2016; 8():59. PubMed ID: 27231488
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules.
Arif M; Pradhan SK; Thanuja GR; Vedamurthy BM; Agrawal S; Dasgupta D; Kundu TK
J Med Chem; 2009 Jan; 52(2):267-77. PubMed ID: 19086895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
